Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of EDIT will rise by +7.29% over the next 2 Weeks and hit $3.30 by Thursday, September 17, 2026. In that time frame, EDIT's share price is expected to range between $3.18 and $3.43.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 17, 2026 | 3.18 | 3.30 | 3.43 |
| Sep 16, 2026 | 3.17 | 3.30 | 3.44 |
| Sep 15, 2026 | 3.14 | 3.27 | 3.39 |
| Sep 14, 2026 | 3.06 | 3.18 | 3.31 |
| Sep 11, 2026 | 3.06 | 3.19 | 3.32 |
| Sep 10, 2026 | 3.07 | 3.19 | 3.32 |
| Sep 9, 2026 | 3.06 | 3.19 | 3.31 |
| Sep 8, 2026 | 3.03 | 3.15 | 3.28 |
| Sep 7, 2026 | 2.95 | 3.07 | 3.20 |
| Sep 4, 2026 | 2.96 | 3.08 | 3.20 |
EDIT shares rose +4.87% in Friday, September 4, 2026's trading session, rising from a previous close of $3.08 to move at $3.23. The stock demonstrated notable intraday movement (see EDIT's key stats for a full breakdown), fluctuating between $3.04 and $3.23, a +6.25% trading range. While recent weeks have seen some volatility, EDIT has managed to secure a +7.67% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.39M shares changing hands, 9.38K more than the previous session. This amounted to $4.48M in total market activity.
Will EDIT Continue Its Upward Trend?
According to analyst ratings and projections for EDIT, Editas Medicine, Inc. shares are anticipated to increase by +5.94%, potentially reaching $3.43 per share by September 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for EDIT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the EDIT stock forecast, now is a good time to buy EDIT stock because its current trading price is -2.25% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on EDIT covering social and institutional perspectives.
EDIT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into EDIT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.79% to 59.89%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.14%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.04%, maintains a neutral outlook for the long term. Insights into EDIT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Editas Medicine Short-Term Forecasts
EDIT Forecast For Next 5 Days
Our algorithm anticipates Editas Medicine (EDIT) stock could hit $3.26 by Sep 11, 2026. This represents a +0.79% fall from today's price, following a -5.16% change over the past five days.
EDIT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Editas Medicine, Inc. (EDIT) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.18, which would mean a -1.55% decrease from the current price of $3.23. Projections for this period range from a high of $3.86 to a low of $2.58.
EDIT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Editas Medicine's price over the next three months point to a rise. EDIT stock is expected to peak at $14.74 on Dec 02, 2026 after potentially dipping to $7.85 on Sep 14, 2026. On average, EDIT is likely to trade around $10.29 in the coming 90 days.
Editas Medicine Stock Forecast 2025
Based on our predictive models, Editas Medicine (EDIT) is expected to trade between $7.85 and $15.61 throughout 2026. This would result in an average price of $11.22, potentially offering investors a +247.37% return from current levels.
Editas Medicine, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Editas Medicine, Inc. (EDIT) is positioned to show a strong performance in September 2026. The price is predicted to move between $7.85 and $8.80, settling at an average of $8.32. This could translate to a +157.59% gain.
October 2026
Based on current market signals, Editas Medicine, Inc. is projected to trend october 2026. We forecast a trading range from $8.39 to $10.03, with a likely average price of $9.46. Investors could expect a potential return of +192.88%.
November 2026
Our predictive algorithms indicate Editas Medicine, Inc. stock may see a shift in November 2026. The expected range spans $9.79–$14.47, with an average target of $12.19. This represents a positive outlook and a possible gain of +277.40%.
December 2026
Analyzing established trends, Editas Medicine, Inc. looks set to move in December 2026. Projections place the stock between $12.96 and $15.61, averaging around $14.42. This suggests a +346.44% gain from current levels.
January 2027
Market indicators suggest Editas Medicine, Inc. could experience notable changes during January 2027. Prices could fluctuate within $9.04 to $15.25, with a midpoint forecast of $12.75. The stock might deliver a +294.74% gain.
February 2027
Forecasting for February 2027, models estimate that Editas Medicine, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $8.70 and $19.08, averaging $13.17. This signals a positive trajectory with potential returns around +307.74%.
March 2027
According to our latest forecast models, Editas Medicine, Inc. (EDIT) is positioned to show a strong performance in March 2027. The price is predicted to move between $12.99 and $22.44, settling at an average of $18.85. This could translate to a +483.59% gain.
April 2027
Based on current market signals, Editas Medicine, Inc. is projected to trend april 2027. We forecast a trading range from $11.68 to $21.54, with a likely average price of $17.48. Investors could expect a potential return of +441.18%.
May 2027
Our predictive algorithms indicate Editas Medicine, Inc. stock may see a shift in May 2027. The expected range spans $11.65–$25.75, with an average target of $18.41. This represents a positive outlook and a possible gain of +469.97%.
June 2027
Analyzing established trends, Editas Medicine, Inc. looks set to move in June 2027. Projections place the stock between $9.52 and $25.25, averaging around $17.32. This suggests a +436.22% gain from current levels.
July 2027
Market indicators suggest Editas Medicine, Inc. could experience notable changes during July 2027. Prices could fluctuate within $9.43 to $26.32, with a midpoint forecast of $17.27. The stock might deliver a +434.67% gain.
August 2027
Forecasting for August 2027, models estimate that Editas Medicine, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $10.40 and $28.37, averaging $18.55. This signals a positive trajectory with potential returns around +474.30%.
September 2027
According to our latest forecast models, Editas Medicine, Inc. (EDIT) is positioned to show a strong performance in September 2027. The price is predicted to move between $10.98 and $28.74, settling at an average of $19.61. This could translate to a +507.12% gain.
EDIT's history of dividends and stock splits also plays a role in long-term investor confidence.